4-methoxyamphetamine has been researched along with Epilepsy Progressive Myoclonic 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackerley, CA; Kumar, S; Minassian, BA; Muralitharan, S; Naranian, T; Ren, ZP; Turnbull, J | 1 |
1 other study(ies) available for 4-methoxyamphetamine and Epilepsy Progressive Myoclonic 2
| Article | Year |
|---|---|
Lafora progressive myoclonus epilepsy: disease course homogeneity in a genetic isolate.
Topics: Adolescent; Adult; Age of Onset; Carrier Proteins; Consanguinity; Death; DNA Mutational Analysis; Humans; Lafora Disease; Oman; Population Groups; Skin; Ubiquitin-Protein Ligases | 2008 |